A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2751104
下载链接
链接失效反馈官方服务：
资源简介：
A multicenter trial to investigate TBio-4101, an autologous, neoantigen-selected, tumor-reactive TIL product, in patients with advanced solid malignancies.
创建时间：
2023-01-15
